{
  "id": 6600506,
  "title": "Blood protein analysis suggests a lung disease drug could be fighting aging at the same time",
  "url": "https://urgent.news/2026/09/10/blood-protein-analysis-suggests-a-lung-disease-drug-could-be-fighting",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-10T14:20:09.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-blood-protein-analysis-lung-disease.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "In 2025, Insilico Medicine developed an experimental drug called rentosertib as a treatment for idiopathic pulmonary fibrosis, a severe age-related lung disease. The drug works by inhibiting the protein TNIK, which is involved in both scar tissue formation in the lungs and fundamental hallmarks of biological aging. The researchers wondered whether rentosertib could serve as a dual-purpose drug…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}